장마감
로그인 회원가입
MOBI
MOBI
Mobia Medical Inc
7월 27일 4:00 PM ET (한국 7/28 05:00)
$11.13
+0.28 ▲ +2.58%
🌙 7월 27일 7:34 PM ET (한국 7/28 08:34)
$11.13
+0.00 +0.00%

모비아 메디컬(MOBI) is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.

시황 · 실적발표 · 매수매도 신호, 가장 먼저 받아보세요 🔔 구독
시가총액
$370M
스몰캡
P/E
-
배당수익률
없음
52주 위치
19%
저점 +9% · 고점 -27%
애널리스트
적극 매수
B+
Fundamental health
vs. Medical Devices· based on 2 axes
수익성
데이터 부족
성장
Top 37%
밸류에이션
데이터 부족
재무 안정
Top 16%
Index -P/E -EPS (ttm) -Insider Own 50.66%Shs Outstand 33.3MPerf Week -7.33%
Market Cap 0.37BForward P/E -EPS next Y 19.63%Insider Trans 9.41%Shs Float 16.4MPerf Month -14.45%
Enterprise Value 0.54BPEG -EPS next Q -0.71Inst Own 0.01%Short Float 2.58%Perf Quarter -
Income -P/S -EPS this Y 95.07%Inst Trans 6.91%Short Ratio 2.06Perf Half Y -
Sales -P/B -EPS next 5Y 66.03%ROA -Short Interest 0.42MPerf YTD -20.5%
Book/sh -5.05P/C 6.64EPS past 3/5Y -ROE -52W High -27.21% ($15.29)Perf Year -
Cash/sh 1.68P/FCF -Sales past 3/5Y -ROIC -52W Low 9.28% ($10.19)Perf 3Y -
Dividend Est. -EV/EBITDA -EPS Y/Y TTM -Gross Margin -Volatility(W/M) 6.37% 8.29%Perf 5Y -
Dividend TTM -EV/Sales -Sales Y/Y TTM -Oper. Margin -ATR (14) 0.98Perf 10Y -
Dividend Ex-Date -Quick Ratio 5.25EPS Q/Q -Profit Margin -RSI (14) 40.45Recom 1
Dividend Gr. 3/5Y -Current Ratio 5.76Sales Q/Q -SMA20 -9.63% ($12.32)Beta -Target Price $17.25
Payout -Debt/Eq 4.09Earnings 2026/8/11SMA50 -12.6% ($12.73)Rel Volume 0.41Prev Close $10.85
Employees 167LT Debt/Eq 4.06EPS/Sales Surpr. -2.77% -0.09%SMA200 -12.22% ($12.68)Avg Volume(3M) 0.21MPrice $11.13
IPO 2026/5/8Option/Short No/YesTrades 1112Volume 84,659Change 2.58%

📊 Mobia Medical Inc (MOBI) Investment Analysis

What kind of company is Mobia Medical Inc?

모비아 메디컬(MOBI) 초고성장주
Healthcare · Medical Devices
Small-Cap — Low Volume, High Volatility

🧠 MicroPort Scientific subsidiary Mobio Medical is a U.S.-based neuromodulation company that develops and sells vagus nerve stimulation (VNS) medical devices designed to aid motor function rehabilitation in patients suffering from chronic ischemic stroke. Its flagship product, the Vivistim system, is paired with rehabilitation therapy to support upper-limb motor recovery and is being rolled out primarily through stroke centers across the United States.

Learn more about Mobia Medical Inc →
Market Cap
$0.4B
Approx. KRW 0.5 trillion
⚖️ 0% of Samsung Electronics
Market Cap Rank3484
Employees167people
IPO2026/05/08
Current Price$11.13 ≈ 15,248원
NASD · USA

Key Events

⏰ Upcoming events
🔔 Earnings release D-14
예상 EPS $-0.71
🎯 Ex-dividend date
No scheduled dividends
📜 Recent events
🔔 Earnings release 2026년 6월 3일 (수) · 장 마감 후 EPS -2.8% 매출 -0.1%
🔔 Earnings release 2026년 2월 25일 (수) · 장 마감 후

Is it profitable?

Financial health solid
Financial health — Debt & liquidity burden
Debt-to-Equity (D/E)
Debt relative to equity (lower is healthier)
4.09
✓ Very high debt
My positionBottom 25%
Low range Average High range
Medical Devices Median 0.39
💡 일반적으로 1.0 이하면 건전, 1.5까지는 무난 (금융·유틸·REIT는 구조적으로 높음)
Current Ratio
Liquid assets available to cover liabilities due within a year
5.76
✓ 우수
My positionTop 25%
Low range Average High range
Medical Devices Median 2.91
💡 1.5~3.0 적정, 1.0 미만이면 단기 유동성 주의
Quick Ratio
Liquid assets excluding inventory, available for immediate use
5.25
✓ 우수
My positionTop 25%
Low range Average High range
Medical Devices Median 2.09
💡 1.0 이상이면 안전, 0.5 미만이면 주의
* Ratings reflect relative position vs. peer-group distribution (same sector & size) plus absolute guards (loss & risk thresholds).

What's the outlook?

Positive Outlook
Price targets, growth, and valuation are favorable
애널리스트 목표가
$17.25
현재가 대비 +55.0%
💡 12개월 이내 도달을 전망하는 애널리스트 컨센서스 평균
내년 EPS 예상 성장률
+19.6%
💡 10% 이상이면 견조한 성장, 마이너스는 이익 감소 예상
5년 EPS 예상 연평균
+66.0%
💡 장기 성장 전망. 15% 이상이면 고성장 기업
⚠ 이 데이터는 애널리스트 추정치이며 실제 결과와 다를 수 있습니다. 투자 결정은 추가 검토와 함께 하세요.

Did earnings meet expectations?

High Earnings Volatility
Frequently misses analyst estimates
0
예상 상회
0
예상 부합
1
예상 하회
0%
상회 비율
-2.8%
평균 서프라이즈
2026.06.03
하회
-2.8%
💡 예상보다 높은 실적을 자주 내는 기업은 실적 신뢰도가 높다고 평가됩니다. 단, 애널리스트 기대치가 낮게 설정되었을 수도 있으니 절대 수치도 함께 봐야 합니다.

Is it growing?

Strong Growth
Above the industry average, both historically and going forward
🔮 How much will it grow? (analyst forecasts)
This Year's EPS Outlook
Projected EPS growth rate for this year
+95.1%
양호
My positionMid-range
Low range Average High range
초고성장주 소형주 Median 51.6% · Top 25%
Next Year's EPS Outlook
Projected EPS growth rate for next year (analyst consensus)
+19.6%
평균
My positionMid-range
Low range Average High range
초고성장주 소형주 Median 33.7% · Bottom 35%
5-Year EPS CAGR Outlook
Projected average annual EPS growth over the next 5 years
+66.0%
우수
My positionTop 25%
Low range Average High range
초고성장주 소형주 Median 40.0% · Top 22%
* Forecast values are analyst consensus estimates. Ratings are determined by relative position vs. peer group of the same growth style and size.

Has the stock risen over the long term?

Returns by period
Current position within 52-week range
Low (-9.3%p) High (-27.2%p)
Current price is 9.3% above the 52-week low and 27.2% below the 52-week high
Recent risk (last 53 trading days)
Max drawdown
-25.8%
Annualized volatility
67.5%

Technical Indicators

Bollinger Bands · MACD · RSI · Stochastics · Ichimoku 5-line · recent 54-day series

Price · Bollinger Bands · Ichimoku Cloud

  • close
  • BB Upper
  • BB Mid
  • BB Lower
  • Tenkan
  • Kijun
  • Cloud (SpanA/B)

Bollinger Bands are upper and lower channels showing the closing price range (20 days · 2σ). Touching the upper band = overheated; touching the lower band = oversold. Ichimoku Cloud shows trend direction and strength through colored areas. Prices above the cloud indicate an uptrend; prices below indicate a downtrend. About Bollinger Bands →

🔴
Current diagnosis · 2026-07-27
Downtrend zone

Current price $11.13 below the midline ($12.32). Normal downward flow. Below the Ichimoku cloud (bearish).

MACD (12 · 26 · 9) Expand ▼

An indicator that uses the difference between the short-term EMA (12) and long-term EMA (26) to identify trend reversals. When MACD rises above the Signal line, it is a buy signal (golden cross); when it falls below, it is a sell signal (death cross). About MACD →

🔴
Current diagnosis · 2026-07-27
Bearish momentum holding

MACD -0.523 < Signal -0.371 in negative zone + Hist negative (-0.153). Weakness in progress.

RSI(14) · Stochastics %K(14) Expand ▼

RSI measures short-term buying and selling pressure on a scale of 0–100. 30 or below = oversold (a rebound may be possible); 70 or above = overbought (a pullback may be possible). Stoch %K similarly measures short-term momentum strength. RSI · Learn more about Stochastics →

🔴
Current diagnosis · 2026-07-27
Bearish zone

RSI 40.4 (below the neutral level of 50). Selling pressure leads, indicating a weak trend. Stoch %K is also 17.4.

※ "Current diagnosis" is an automated interpretation based on standard thresholds and is for reference only. Make your own comprehensive judgment before trading.

Is it attractive at this price?

Valuation data is insufficient

Key metrics such as PER and PBR are unavailable, so valuation is omitted.

Who owns it?

Ownership flow is positive
Insider modest net buying +9.4% · Institutional net buying +6.9% · Short interest light 2.6%
📈 Recent trading flow (6 months)
🧑‍💼 Insiders (executives & directors)
+9.4%
Insiders net buying
🏦 Institutions (funds & investors)
+6.9%
Institutions net buying
💡 Net change over the past 6 months. Shows how much insiders and institutions increased or reduced their holdings, in %.
👥 Holdings composition
🏦 Institutions 0.0%
Retail-led
Healthcare 소형주 Median 65.6%
🧑‍💼 Insiders 50.7%
Founder/management large holders (strong skin-in-the-game)
Healthcare 소형주 Median 17.6%
👤 Retail investors (estimated) 49.3%
Everyone excluding institutions and insiders
Institutions Insiders Retail (est.)
📉 Short-selling metrics
Short ratio
2.6%
Low — limited short-side pressure
Healthcare 소형주 Median 11.2%
Past 40 days Little change
Short interest days to cover
2.1 days
Days needed to close short positions using average trading volume
🧮 Share count
Total shares outstanding 33.3M주
Float (tradable shares) 16.4M주
* Insider/institutional flows are based on net changes over the past 6 months. Trend is cumulative over the past 40 days.

How much does it pay in dividends?

This company does not pay a dividend

It may be a growth-focused firm reinvesting profits into expansion. Consider this growth-stock profile when investing.

Compare Industry Peers

💡 vs. sector average ▲ Favorable / ▼ Unfavorable (Lower PER and PBR are better; higher ROE and dividend yield are better)
Sorted by market cap, largest first
StockMarket CapPERPBRROEDividend YieldChange
MOBI MOBI This Stock
$370.1M- - - - +2.6%
LLY
$1.13T43.1 36.2 107.64% 0.58% +0.1%
JNJ
$640.9B30.8 7.5 25.74% 2.02% +1.0%
ABBV
$453.9B126.7 - 15221.82% 2.67% -0.9%
UNH
$379.3B26.9 3.9 12.49% 2.16% -0.7%
MRK
$323.0B36.8 7.0 18.97% 2.5% -0.2%
Sector Avg-26.12.7-48.83%1.23%-
📊
See the market at a glance with a real-time dashboard Track premarket, regular, and after-hours quotes, screeners, and heatmaps on a single screen

FAQ

What kind of company is 모비아 메디컬(MOBI)?

모비아 메디컬(MOBI) belongs to the Healthcare sector and operates in the Medical Devices industry.

What is the market cap of MOBI?

The market cap of MOBI is approximately $370M, ranking 3,484 within its sector.

What is the 52-week high and low for MOBI?

MOBI has recorded a 52-week high of $15.29 and a low of $10.19.

시황 · 실적발표 · 매수매도 신호, 가장 먼저 받아보세요 🔔 구독

면책조항: 본 콘텐츠는 참고 자료이며 투자 권유가 아닙니다. 모든 투자의 책임은 투자자 본인에게 있습니다.